Several larger med-tech companies are making efforts to reposition themselves toward cutting edge technologies, according to the latest M&A report from the Walden Group (Tarrytown, New York). The firm's 2Q11 report suggests that the "sluggish economic recovery," and the "U.S. budget mess in Washington," are driving this trend by making traditionally high volume products such as hip and knee implants less predictable and profitable. (Medical Device Daily) Read More
